Complete Remission in a Colon Cancer Patient with a Large, Irresectable Liver Metastasis after XELOX/Cetuximab/Bevacizumab Treatment

Publisher： Karger

E-ISSN： 2296-5262|31|8-9|464-467

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.31, Iss.8-9, 2008-08, pp. : 464-467

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of XELOX plus Bevacizumab in Brain Metastasis from Rectal Cancer

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-02 ,pp. : 117-121

Karger

Access to resources Recommend Favorite

Durable Complete Remission of a Brainstem Glioma Treated with a Combination of Bevacizumab and Cetuximab

By  

Case Reports in Oncology, Vol. 5, Iss. 3, 2012-12 ,pp. : 676-681

Karger

Access to resources Recommend Favorite

Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K‐ras status for unresectable colorectal liver metastasis (BECK study)

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 8, 2015-08 ,pp. : 634-645

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Complete Remission with nab-Paclitaxel, Bevacizumab, and Gemcitabine Combination Therapy in a Patient with Triple-Negative Metastatic Breast Cancer

By  

Case Reports in Oncology, Vol. 5, Iss. 3, 2012-12 ,pp. : 687-692

Karger

Access to resources Recommend Favorite

Effective Second-Line Treatment with Cetuximab and Bevacizumab in a Patient with Hepatic Metastases of Colorectal Cancer and Hyperbilirubinemia

By  

Oncology Research and Treatment, Vol. 30, Iss. 10, 2007-09 ,pp. : 509-512

Karger

Access to resources Recommend Favorite